Abstract: Post-translational modifications such as phosphorylation are known to play an important role in the gene regulation by the transcription factors including the nuclear hormone receptor superfamily of which the glucocorticoid receptor (GR) is a member. Protein phosphorylation often switches cellular activity from one state to another. Like many other transcription factors, the GR is a phosphoprotein, and phosphorylation plays an important role in the regulation of GR activity. Cell signaling pathways that regulate phosphorylation of the GR and its associated proteins are important determinants of GR function under various physiological conditions. While the role of many phosphorylation sites in the GR is still not fully understood, the role of others is clearer. Several aspects of transcription factor function, including DNA binding affi nity, interaction of transactivation domains with the transcription initiation complex, and shuttling between the cytoplasmic compartments, have all been linked to site-specifi c phosphorylation. All major phosphorylation sites in the human GR are located in the N-terminal domain including the major transactivation domain, AF1. Available literature clearly indicates that many of these potential phosphorylation sites are substrates for multiple kinases, suggesting the potential for a very complex regulatory network. Phosphorylated GR interacts favorably with critical coregulatory proteins and subsequently enhances transcriptional activity. In addition, the activities and specifi cities of coregulators may be subject to similar regulation by phosphorylation. Regulation of the GR activity due to phosphorylation appears to be site-specifi c and dependent upon specifi c cell signaling cascade. Taken together, site-specifi c phosphorylation and related kinase pathways play an important role in the action of the GR, and more precise mechanistic information will lead to fuller understanding of the complex nature of gene regulation by the GR-and related transcription factors. This review provides currently available information regarding the role of GR phosphorylation in its action, and highlights the possible underlying mechanisms of action.
Introduction
The glucocorticoid receptor (GR) belongs to the superfamily of the hormone-activated intracellular transcription factors, the nuclear hormone receptors (NHRs). Most of the biological effects of glucocorticoids are mediated through the GR and occur at the level of regulation of gene transcription (Evans 1988; Beato 1989; Yamamoto 1985) . The role of the GR, which acts in a ligand-, cell type-, and promoter-specifi c manner is important in the transcriptional activation of genes involving the regulated assembly of multiprotein complexes on enhancers and promoters (Simons 1994; Kumar et al 1999a; Rogatsky et al 2003) . The classical mechanism of steroid/hormone action ( Figure 1 ) (Dean et al 1996; Kumar et al 1999b; Nissen et al 2000; Mendelson 2004) states that the GR in its inactive form is located in the cytoplasm, and after entry into the cell the steroid/hormone fi nds the receptor as part of a large heteromeric complex consisting of several proteins including HSP90, HSP70, Immunophilins, FKBPs, CyP-40, P23, and possibly others (Housley et al 1985; Sanchez et al 1987; Pratt et al 1997 Pratt et al , 2003 Silverstein et al 1999; Shikama et al 2000; Davies et al 2002; Morishima et al 2003) . Steroid binding leads to the disassembling of the complex through conformational changes in the receptor molecule and the activated receptor enters the nucleus, where it interacts with critical regulatory sites on the relevant genes (Hollenberg et al 1987; Orti et al 1992; Henriksson et al 1997; Horwitz et al 1996; Starr et al 1996; Lefstin et al 1998; Yamamoto et al 1998; McKenna et al 1999; Kumar et al 2003; Rogatsky et al 2003; Weigel et al 2007a Weigel et al , 2007b ). The classic model for steroid action states that the DNA bound receptor collects a variety of ancillary factors which modify chromatin structure and/or contact the primary transcription complex machinery proteins such that transcription from the relevant promoter can be either enhanced or repressed. However, this has led to the problem of understanding how the receptor molecule makes such large protein surface areas available to accommodate specifi c sites for all these factors. The molecular mechanisms to explain this phenomenon have not been fully defi ned.
There are possibilities that some of these actions can be explained on the basis of post-translational modifi cations of specifi c NHRs. In spite of the fact that GR is a hormoneactivated transcription factor, its expression and many physiological activities are highly regulated by post-translational modifi cations (Webster et al 1997; King et al 1998; Wallace et al 2001; Le Drean et al 2002; Tian et al 2002) . One such important post-translational modifi cation associated with GR function is site-specifi c phosphorylation (Wang et al 2002; Ismaili et al 2004; Duma et al 2006) . Involvement of several known phosphorylation sites in the GR and variety of kinases facilitates integration between cell-signaling pathways and the GR action (Krstic et al 1997; Rogatsky et al 1998a) . Most, if not all known phosphorylation sites in the GR are localized within the N-terminal domain (NTD) that contains a major transactivation domain, AF1 (Bodwell et al 1991 (Bodwell et al , 1998 Blind et al 2004; Kumar et al 2004a) .
Post-translational modifi cations including phosphorylation are generally an important phenomenon in regulation of protein function in eukaryotic cells, and are often concerned with switching of a cellular activity from one state to another (Auricchio 1989; Orti et al 1989; Kuiper et al 1994) . It is now well accepted that for several transcription factors including GR, site-specifi c phosphorylation can modulate their DNA binding affi nity, the interaction of transactivation domains of these transcription factors with components of the transcription initiation complex, and the shuttling of transcription factors between the cytoplasmic compartments (Bai et al 1995; Rogatsky et al 1998b; Wang et al 1999; Gioeli et al 2002) . There are several reports showing that kinases can phosphorylate GR at multiple sites leading to altered GR activity (Blind et al 2004; Ismaili et al 2004) . Depending upon the kinases involved, the GR activity can be both up-or down-regulated (Ismaili et al 2004) . For example, phosphorylation of GR by cyclin-dependent kinases (Cdk1, Cdk2, and cdk5) leads to up regulate GR activity (Ismaili et al 2004; Weigel et al 2007a) , whereas JNK and GSK3 inhibits GR activity through direct phosphorylation of GR (Rogatsky et al 1998a (Rogatsky et al , 1998b . In contrast, certain kinases such as p38 MAPK Figure 1 Classical action of the glucocorticoid signaling mediated by the GR. Unliganded receptor is located in the cytosol associated with several heat shock and other chaperone proteins including HSP90, HSP70, CyP-40, P23, and FKBPs (shown by different shapes and shades in the cytosol). Ligand binding leads to conformational alterations in the GR, and by doing so GR dissociates from these associated proteins, and ligand bound GR is free to translocate to the nucleus. This process appears to be phosphorylationdependent. Once in the nucleus, GR dimerizes and binds to site-specifi c DNA binding sequences and interacts with several other coregulatory proteins including coactivators and proteins from the basal transcription machinery including SRCs, CBP/p300, DRIP/TRAP, TBP, GRIP1, and several others (shown by different shapes and shades) in the nucleus, and subsequently leading to transcriptional regulation.
are reported to both up-and down-regulate GR activity, these effects of p38 MAPK appears to be cell-specifi c (Szatmary et al 2004; Miller et al 2005) .
Some of the GR phosphorylation sites are conserved across species, whereas others are unique to specifi c species (Ismaili et al 2004) . Generally, GR phosphorylation is liganddependent, which suggests that this may be a determinant of promoter specifi city, interaction with coregulatory proteins, and even GR stability (Webster et al 1997; Zhou et al 2005; Faus et al 2006) . There are several kinases that phosphorylate the GR with the resultant phosphorylation enhancing GR transcriptional activity (Ismaili et al 2004) . However, GR can also be phosphorylated in a ligand independent manner as well (Ismaili et al 2004 (Ismaili et al , 2005 . In fact, we have earlier shown that p38 MAPK can phosphorylate human GR fragment lacking the LBD, which enhances the transactivation activity of the GR and mediates GR-dependent apoptosis in cells transfected with this fragment (Miller et al 2005) . We also found that p38 was activated probably through immediate upstream activators, MKK3 and MKK6, both specifi c to p38 (Miller et al 2005) . In addition, MKK4, whose best-known substrate is JNK, can also phosphorylate p38. In recent years, it is becoming clearer that many receptor phosphorylation sites are substrates for multiple kinases, suggesting towards potential for very complex regulatory patterns. In this review article, we have summarized knowledge regarding the role of GR phosphorylation in the regulation of receptor function, and the possible underlying mechanisms of action.
The structural arrangements of the glucocorticoid receptor (GR)
The GR protein consists of a domain structure arrangement, typical of the superfamily of the NHRs (Yamamoto 1985; Evans 1988; Beato 1989; Simons 1994; Kumar et al 1999) . This modular conceptual framework has been useful, but it has become clear that there are certain limits to the domain. This fundamental domain model divides the primary sequence into NTD, DNA-binding domain (DBD) (Hard et al 1990; Luisi et al 1991) , and LBD with "activation function" (AF2) sub-domain that regulates transcription (Giguere et al 1986; Hollenberg et 1987; Bocquel et al 1989; Ikonen et al 1997; Metivier et al 2001; Bledsoe et al 2002) . Ligand binding to the LBD results in conformational rearrangement of its AF2 sub-domain (usually helix 12) such that its surfaces are available for interactions with specifi c coregulatory proteins through LXXLL motifs. The GR and several other receptors in the family have long NTD . In these is found another, potent transactivation domain, AF1 Miesfeld et al 1987) . Cooperative binding and site specifi city combine for GR:GRE tethering allows receptor's interaction with the transcription initiation complex, directly by interactions between AF1/AF2 and the complex, or indirectly through specifi c coregulators . To a fi rst approximation, this conceptual model is useful, but fails to explain several essential facts such as the role of post-transcriptional modifi cations, including sumoylation, acetylation, and site-specifi c phosphorylation. Our recent data and available literature from other laboratories clearly indicate an important role of GR phosphorylation and involvement of specifi c kinases (Rogatsky et al 1998a; Ismaili et al 2004; Miller et al 2005) . Other data suggests that intramolecular signaling occurs as well between the amino-terminal and LBD regions (Ikonen et al 1997; Hittelman et al 1999; Tetel et al 1999; Kumar et al 1999; Bommer et al 2002) . To fully understand the mechanisms of action of the GR, we must understand the answer to the above mentioned fundamental questions.
Phosphorylation regulates structure and functions of the GR
Like many other transcription factors, the GR is a phosphoprotein, which becomes hyperphosphorylated upon steroid binding, and it has been suggested that phosphorylation plays an important role in the regulation of GR activity (Ismaili et al 2004) . Protein phosphorylation is generally an important regulatory mechanism for protein function in eukaryotic cells, and is often concerned with switching of a cellular activity from one state to another. Phosphorylation of the Pol II protein complex is correlated with the transition between transcriptional initiation and elongation (Nissen et al 2000; Pinhero et al 2004) ; thus phosphorylation may be involved in transcriptional regulation. In recent years, more and more evidence point towards the role of phosphorylation and other post-translational modifi cations in the gene expression and regulation of many transcription factors (Boyle et al 1991; Nichols et al 1992; Wisniewski et al 1999) .
Cellular kinases play a prominent regulator role for the NHR (Ismaili et al 2004) . Ligand binding, nuclear translocations, modulation of binding to REs, receptor dimerization, and interaction with general transcription factors, have all been linked to phosphorylation (Ismaili et al 2004) . It has been reported that kinases enhance the transactivation activity of several steroid receptors both in a liganddependent and ligand-independent manner (Rogatsky et al 1998b; Ismaili et al 2004) . For transcription factors, three main mechanisms of regulation by phosphorylation can be identifi ed; 1) the DNA binding affi nity of transcription factors can be modulated negatively or positively; 2) the interaction of transactivation domains of transcription factors with components of the transcription initiation complex can be affected; and 3) the shuttling of transcription factors between the cytoplasmic compartments can be infl uenced.
In the human GR fi ve serine residues (S113, S141, S203, S211, and S226) have been identifi ed (Ismaili et al 2004) , whereas in the mouse GR there are eight phosphorylation residues identifi ed. In mice, seven of the 8 phosphorylation sites are at serine residues (S122, S150, S212, S220, S234, S315, and S412) and one at threonine (T159) (Bodwell et al 1991; Bodwell 1998; Rogatsky et al 1998a) . All the known phosphorylation sites identifi ed in mouse GR are found in the NTD, in or near the AF1 domain (Mason et al 1993) . Several kinases are reported to be involved in the phosphorylation of these sites, such as mitogen protein kinases (MAPK), cyclin-dependent kinase (CDK) (Krstic et al 1997) , glycogen synthase kinase-3 (GSK-3), and c-Jun N-terminal kinases (JNK) (Rogatsky et al 1998a) . Though, each of these kinases is reported to show distinct specifi cities for potential phosphorylation residues, full receptor activity may require synergistic effects of these kinases and their signaling cascades.
In the human GR AF1, major functionally important known phosphorylated residues are S203, S211, and S226 (ure 2). At least two of these (S211 and S226) are thought to be important for transcriptional activity of the GR (Rogatsky et al 1998b; Ismaili et al 2004; Miller et al 2005) . The use of site-specifi c antibodies has shown that S203 phosphorylation is involved in the GR translocation (Ismaili et al 2004) . It has also shown that site-specifi c (S211) phosphorylation of the GR AF1 enhances its interaction with a protein from the DRIP/TRIP complex, and subsequently GR activity (Blind et al 2004; Ismaili et al 2004) . These observations clearly suggest that site-specifi c phosphorylation in GR AF1 may regulate GR function, in an AF1-dependent manner. However, it is not yet known exactly how phosphorylation infl uences the structure and functions of the GR AF1.
The AF1 can act constitutively in the absence of LBD, and is quite active in stimulating transcription from simple promoters containing cognate binding sites(s). Because GR AF1 exists in intrinsically disordered conformation(s), advances in understanding its structure and functions have been slowed (Dahlman-Wright et al 1995; Baskakov et al 1999; Kumar et al 2004b) . It is known that for function AF1 interacts with specifi c coregulatory proteins such as CBP, TBP, TIF2, DRIP/TRAP, Ada among others, and the available data strongly suggest that AF1 must adopt an ordered conformation to optimize interactions and subsequent transcriptional activity . In recent years, it has become quite evident that eukaryotic genomes are highly enriched in intrinsically disorder proteins relative to prokaryotes, refl ecting the greater need for signaling and regulation in nucleated cells (Crivici et al 1995; Namba 2001; Dyson et al 2002; Iakoucheva et al 2002; Tompa 2002; Romero et al 2004; Ward et al 2004; Liu et al 2006) . These disordered protein regions/domains promote molecular recognition primarily through unique combination of high specifi city and low binding affi nity with their functional binding partners, recognize and bind a number of biological targets, and create propensity to form large interaction surfaces suitable for interactions with their specifi c binding partners (Crivici et al 1995; Namba 2001; Iakoucheva et al 2002; Dyson et al 2002; Tompa 2002; Romero et al 2004; Ward et al 2004; Liu et al 2006) . We hypothesize that site-specifi c phosphorylation of the GR AF1 leads to changes in its conformations that are important for AF1's interaction with other critical coregulatory proteins, and subsequent transcriptional activity. Shown from left to right: S113, S141, S203, S211, S226, and S308. Corresponding amino acids in the rat GR are S134, S162, S224, S232, S246, and S329, whereas in the mouse GR these correspond to S122, S150, S212, S220, S234, and S315. In the rat and mouse GR, there is one Threonine residue (T171 in rat and T159 in mouse) that is known to be phosphorylable, and is not conserved in the human GR. In the human GR except for S308, all other residues are located within the AF1 domain, and S203, S211, and S226 are reported to have to have some functional roles in the action of the GR. Phosphorylation of these sites are kinase-and cell-dependent.
Phosphorylation and glucocorticoid receptor action
There are also reports suggesting that phosphorylation may affect GR stability and thus alter transcriptional activity of the receptor (Zhou et al 2005) . Co-transfection data from Cidlowski and colleagues (Webster et al 1997; Wallace et al 2001) have shown that phosphorylated mouse GR had a half-life of 8-9 h in the presence of agonist, whereas mutations of multiple GR phosphorylation sites increased its half-life to 32 h. All the GR phosphorylation sites that are conserved among human, mouse, and rat are located within the AF1 domain. Single mutations of these do not alter receptor activity in an MMTV-driven promoter-reporter construct, but a GR lacking all fi ve sites that are well conserved in mouse, rat and human GR shows signifi cantly decreased activity (Almlof et al 1995) . Our recent published data however show that p38 and ERK2 are potent kinases for in vitro phosphorylation of S211 (located in AF1 domain) on the human GR (Miller et al 2005) . The mutant lacking a phosphorylatable amino acid at position 211 (S221A) was considerably less potent in inducing the AF1-medited, GRE-driven reporter gene, and GR-mediated apoptosis induced by dexamethasone (Miller et al 2005) . Garabedian and colleagues (Rogatsky et al 1998b; Blind et al 2004; Ismaili et al 2004; Kino et al 2007; Wang et al 2007) have also demonstrated that site-specifi c phosphorylation in GR, particularly S211 and S226 play an important role in gene regulation by the GR, and AF1 appears to be a main player in this process. Thus, in contrast to earlier study that suggested lack of specifi city of phosphorylation (Almlof et al 1995) , these more recent fi ndings clearly indicate the role of site-specifi c phosphorylation in AF1-mediated GR functions (Ismaili et al 2004; Miller et al 2005) .
Role of phosphorylation in protein: protein interactions involving the GR and specifi c coregulators
In the conceptual model of a GR:coactivator complexes, the ligand-bound receptor recruits one or more coactivators, which subsequently results in the recruitment of additional coactivators to the assembly. The histone acetylation and methylation activities of various constituents of the coactivator complex facilitate the relaxation of the chromatin architecture at the target gene promoter, thereby enhancing transcriptional activation. Analogous arguments can be made for GR:corepressors complexes (Horwitz et al 1996; Yamamoto et al 1998; McKenna et al 1999) . The GR AF1 domain is known to play an important role in many of these interactions, via interaction with regions of the coactivator remote from the LXXLL motif . The ability of GR AF1 to interact with components of the general transcriptional machinery or with coregulator complexes provides a broad insight into the process of transcriptional initiation. CBP, TBP, AdA2, DRIP150, TSG101, and several other co-regulators have been shown to bind to the GR AF1 Ismaili et al 2004) . Direct binding of TBP with AF1, raises the possibility that this GR domain somehow directly infl uences the transcriptional machinery. In vitro transcription studies indicated that the holo-GR acts to stabilize the pre-initiation complex (Horwitz et al 1996; Yamamoto et al 1998; McKenna et al 1999) , though other mechanisms to control transcription have recently been reported (Glass et al 1997; Yamamoto et al 1998; Fujita et al 2003; Loven et al 2003) .
It has been reported that the interaction between the GR and TSG101 may be modulated through GR phosphorylation (Ismaili et al 2005) . This study shows that TSG101 is preferentially recruited to the nonphosphorylated form of the GR (Ismaili et al 2005) . Another GR AF1 coregulator DRIP150 is also been reported to be modulated through GR phosphorylation (Ismaili et al 2004) . Our unpublished data (Garza and Kumar, in preparation) show that interaction of several GR AF1 coregulators including TBP, CBP, and SRC-1 are facilitated by GR phosphorylation. Moreover, phosphorylation of several transcription factors, including NHRs enhances recruitment of coregulatory proteins (Wu et al 2005) . Thus, it can be concluded that site-specifi c phosphorylation of the AF1 domain of GR can either enhance or diminish recruitment of coregulators.
These contrasting effects of AF1/GR phosphorylation on recruitment of specifi c coregulators may refl ect the biologic need for the GR to up-or down-regulate gene(s) in a cell-and promoter-specifi c manner. Recent studies have shown that GR site-specifi c phosphorylation can differentially regulate the expression of several target genes (Chen et al 2008; Davies et al 2008; Blind et al 2008) . However, this phenomenon is not clearly understood, and further studies are needed to provide a more comprehensive explanation for this behavior. One clue to the complexity of this system is that SG101 stabilizes ligand-unbound GR in its unphosphorylated form to protect it from degradation. Our recent fi ndings (Garza and Kumar, in preparation) suggest that phosphorylation of the GR stabilizes the conformation of otherwise unstructured AF1 such that AF1's surfaces are available for its interaction with co-regulatory proteins. Thus, TSG101 interaction with GR may be important to keep unliganded GR protected from autodegradation until the GR becomes phosphorylated.
Recent studies suggest that in addition to the receptor phosphorylation, the activities and specifi cities of coregulators are also subject to similar regulation by phosphorylation. For example, the actions of coregulators including SRCs and CBP can be modifi ed by phosphorylation (Tzukerman et al 1994; Chen et al 1999 . Several phosphorylation sites for SRC-1 and SRC-3 have recently been identifi ed (Rowan et al 2000b; Wu et al 2004) . Phosphorylation of these coregulators is induced by steroid hormones (Lopez et al 2001; Wu et al 2004 Wu et al , 2005 , and phosphorylation is critical for optimal activities. These data suggest that phosphorylation of coregulators may infl uence their protein-protein interactions with GR. This concept raised the possibility that the phosphorylation patterns of specifi c coregulator(s) might serve as a signal integrator, permitting this complex network of GR and cofactors to accurately and specifi cally activate a broad range of promoters for transcriptional activation.
Role of phosphorylation on the transactivation activity of the GR
It has been demonstrated that the status of GR phosphorylation can alter its transcriptional activity (Mason et al 1993) . There are reports showing that in human GR S203A and/or S211A mutations signifi cantly repress GR activity, whereas S226A mutation has increased GR activity in a yeast system (Almlof et al 1995) , suggesting that effects of phosphorylation on the GR transcriptional activity could be both up-or down-regulated depending upon the site of phosphorylation, and (due to site-specifi city of the kinase) probably the specifi c kinase pathways involved (Ismaili et al 2004) . Reduced GR activity and decreased level of phosphorylation status have been observed in cells defi cient in the CDK inhibitor p27 (Rogatski et al 1997) . However, other studies show that mutations of multiple GR phosphorylation sites do not signifi cantly alter GRE-mediated GR activity in cell co-transfection studies (Almlof et al 1991) . A number of explanations for these apparently confl icting results exist. For example, some studies were conducted using different promoters, and therefore it is quite possible that the infl uence of the GR phosphorylation on its transcriptional activation activity may be dependent on the promoter context of the target gene. It is also likely that site-specifi c phosphorylation of the GR would contribute to endogenous gene regulation, acting in a cell-type specifi c manner in which the use of kinases might differ (Zhou et al 2005) . Another possible explanation is that individual phosphorylation sites may infl uence translocation to the nucleus (Webster et al 1997) . However, the presence of confl icting data (Wang et al 2007) highlights the complexity of this system, and the need for more studies to establish underlying mechanisms.
We have shown that a mutation of Ser211 to Ala residue reduced GR-mediated transcriptional activation and apoptosis in a human leukemia cell line, suggesting a role for p38 MAPK signaling in glucocorticoid-induced apoptosis of lymphoid cells. With respect to the consequences of p38 MAPK phosphorylation, it has further been shown that S211 residue of AF1 is a specifi c substrate site for p38 MAPK, and that mutation S211A, which prevents phosphorylation at this position, diminishes apoptosis driven by the constitutively active GR lacking the ligand binding domain, suggesting a possible role of AF1-mediated GR transcriptional activity (Miller et al 2005) . However, it is not known whether other phosphorylation sites (eg, S203 and S226) are also involved in this process. Further studies in our laboratory are exploring a variety of possibilities to understand the role of phosphorylation in GR function. Similar effects have been shown in other laboratories, using different cells and kinase pathways (Ismaili et al 2004) . Thus, in contrast to earlier study (Almlof et al 1995) , these recent fi ndings clearly indicate the critical role of site-specifi c phosphorylation of AF1 in regulating GR functions. Activity of steroid bound GR may also be reduced due to site-specifi c phosphorylation (Ismaili et al 2004) . For example, activation of JNK induces rat GR phosphorylation at S246 which signifi cantly reduces GR activity; mutation of S246A, eliminating the potential phosphorylation site, diminishes inhibitory effects of JNK (Ismaili et al 2004) . These results suggest that phosphorylation at S246 either increases its affi nity for a corepressor or decreases its interaction with a coactivator. Thus, site-specifi c phosphorylation and the particular kinase pathways involved in different cell types may dictate the pattern of GR regulation of specifi c target gene(s). Further, these effects may be synergistic in nature.
Additional studies are needed to clarify the underlying mechanisms to determine these effects. A possible role of phosphatases has also been reported to regulate GR phosphorylation and its subsequent effects of the transcriptional activity (Ismaili et al 2004) . Perturbations in protein phosphatase activity have been shown to affect GR function. Treatment of cells with protein phosphatase inhibitor results in enhanced phosphorylation of GR, accumulation of GR in the cytoplasm, and subsequent reduction in GR-mediated transcriptional activation (DeFranco et al 1991; Sommers et al 1992) . However, the effects of specifi c phosphatases (and by extension specifi c phosphatase inhibitor) on site-specifi c GR phosphorylation and function have not been well established. Collectively, the effect of phosphatases on GR signaling and transcriptional regulation is complex, and requires further examination. Thus, it becomes of great importance to determine the pattern, kinetics, extent, and effects of phosphorylation/dephosphorylation in modulating GR action. Subsequently, it will be critical to establish the mechanisms by which modulation of GR activity occurs, and determine whether AF1 phosphorylation, in a site-specifi c manner, is an integrating phenomenon for GR regulation. Although short of actual proof, it seems apparent that both kinases and phosphatases may be interacting in complex ways to determine phosphorylation of specifi c sites within the GR AF1 that may well be cell-and promoter-specifi c in nature.
Summary and perspectives
Steroids have been frontline therapy for decades in the treatment of malignancies and inflammatory disorders; however the mechanism by which steroid receptors pass signals from ligand to regulate specifi c genes is not fully understood. Recent progress combined with classical understanding of the steroid receptors action, and the availability of the structure of individual domains of several members of the NHR superfamily including the GR has provided new understanding of the function of the GR. Recent studies have suggested that under physiological conditions, there are many factors that infl uence the conformation of the GR such that malleable protein surfaces are available for interaction with appropriate coactivators/corepressors. However, it remains to be determined how precisely these GR:protein interactions may differ with different cell-and promoter-specifi c conditions, and how the receptor communicates with transcription initiation machinery. Another important problem that remains to be solved is the precise mechanism by which AF1 and AF2 synergize with each other in the holo-receptor. Post-translational modifi cations including phosphorylation, ubiquitination, and sumoylation have all been shown to affect functions of NHR family members.
In recent years it has become clear that the cross-talk exists between GR signaling and other receptor cascades including infl ammatory kinases (MAPKs, ERK, p38 and JNK) as well as the cAMP-driven PKA pathways. There is evidence that that differential phosphorylation is a potential regulator of species-specifi c actions of the GR. However, current knowledge reveals that the role of GR phosphorylation is a remarkably complex phenomenon. It is evident that the GR is a target for multiple kinases, and that many GR functions are regulated by phosphorylation. Several outstanding questions remain to be answered. For example: 1) what are the relative levels of phosphorylation of individual sites under physiological conditions; 2) how do phosphatases infl uence the cellular machinery; and 3) what is the correlation between cell based studies and in vivo animal models. However, it is clear that GR-mediated glucocorticoid signaling is a multifaceted process involving crosstalk with various regulatory kinase pathways. Thus, signaling cascades that induce phosphorylation of the GR and its coactivator proteins are critical factors in determining the physiological actions of the GR. Further studies that clarify the regulation of endogenous target genes by specifi c phosphorylation site(s) should lead to target-and perhaps tissue-specifi c requirements for phosphorylation. There are several other avenues of post-translational modifi cations that might also affect the actions of GR. Ubiquitination-mediated degradation regulates glucocorticoid signaling by controlling the degradation rates of GR (Kinyamu et al 2005) . Another post-translational modifi cation, sumoylation, can also regulate the GR functions (Le Drean et al 2002) . There are at least three known sumoylation sites in the human GR. Two of them are located in the NTD (K277 and K293) and one (K703) in the LBD (Faus et al 2006) . Acetylation and methylation are other possible modifi cations that may infl uence GR actions; however, there is not enough evidence to suggest their direct role in modulating GR functions. At least one recent study has shown a ligand-dependent acetylation of the human GR at K494 and K495 residues, but the functional consequences of this modifi cation are not clear (Ito et al 2006) .
We propose that under physiological conditions, site-specifi c phosphorylation plays a crucial role in allowing the AF1 domain of the GR to adopt functionally active conformation(s) in vivo (Figure 3) . The resulting structurally modifi ed forms of AF1 suit it for its varied interactions with other critical coregulatory proteins, and possibly additional modulations in receptor structure essential for gene regulation by the GR. These interactions give a set of functionally active folded structure to AF1 and form the basis for the multiprotein assemblies involved in GR-mediated regulation of transcription. How site-specifi c phosphorylation leads to such AF1 conformation(s) and what kind of functional folded conformation it adopts are open questions, and we and others have been pursuing answers to these long-standing problems. Knowledge of the conformational changes in AF1 and/or other domains/regions of the GR due to site-specifi c phosphorylation and subsequently gene regulation will lead to an understanding of the role of this important phenomenon in the transcription process, information essential to understanding how glucocorticoids affect gene regulation.
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Figure 3 A hypothetical model of the role of site-specifi c phosphorylation on the structure and functions of the AF1 domain. The GR AF1 domain exists in an intrinsically disordered (ID) conformation ie, as an ensemble of conformers that collectively appear to lack any signifi cant secondary/tertiary structure. Phosphorylation of one or more sites within the AF1 alters its conformation in such a way that AF1 adopts a partially folded (PD) conformation that facilitates AF1's interaction with one or more of the coregulatory proteins. This protein:protein interaction allows structurally modifi ed forms of AF1 to suit for its varied interactions with other critical coregulatory proteins, and possibly additional modulations in receptor structure essential for gene regulation by the GR. This AF1:coregulators assembly provides optimal ordered conformation in the AF1 for subsequent transactivation activity. Alternatively, one or more of the coregulator proteins directly interact with one or more unphosphorylated AF1 conformers that may trigger phosphorylation of AF1. The resultant assembly of proteins may depend upon the cellular environment, specifi c promoters used, and the kinase pathway involved. All the available phosphorylation sites in the GR could be involved simultaneously or there may be a coordinated synergy between each site. In the full length GR, AF1:coregulators assembly may also be infl uenced by other factors such as DNA binding to its DBD, ligand binding and the cross talk between AF1 and AF2. In addition to the level of AF1 phosphorylation, phosphorylation of different coregulators may also infl uence the outcome, and certain coregulators may be included or excluded from the assembly depending upon the interacting surfaces of the AF1 and/or coregulator proteins. 
